Located within the Deison Technology park, VGXI’s 120,000-square-foot mission-critical headquarters and advanced biopharmaceutical manufacturing facility consolidates research, production, and corporate critical functions under one roof, enabling continuous operation in a highly regulated cGMP environment.
As a leading CDMO, VGXI required scalable, compliant infrastructure to support DNA plasmid and virus production, mRNA manufacturing, and personalized therapies. The facility includes four manufacturing trains, flexible 3,000L+ fermentation capacity, fill-finish suites, and dedicated cleanrooms.
Designed for adaptability and long-term growth, mission-critical systems and modular spaces ensure operational resilience. The facility also features modern office and amenity spaces, reflecting VGXI’s commitment to employee wellness and scientific innovation.